Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: Substantial risks after radiotherapy

Journal of Clinical Oncology

Volumn 24, Issue 16, 2006, Pages 2570-2575

  Sharif, Saba ^b   Ferner, Rosalie ^b   Birch, Jillian M ^b   Gillespie, James E ^b   Gattamaneni, H Rao ^b   Baser, Michael E ^b   Evans, D Gareth R ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM TUMOR; NEUROFIBROMATOSIS; NEWBORN; OPTIC NERVE GLIOMA; PRIORITY JOURNAL; REVIEW; SECOND CANCER; ARTICLE; DRUG CONTRAINDICATION; PRESCHOOL CHILD; RADIOTHERAPY; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; NEOPLASMS, SECOND PRIMARY; NEUROFIBROMATOSIS 1; OPTIC NERVE GLIOMA; RADIOTHERAPY; RISK ASSESSMENT; RISK FACTORS;

EID: 33745001462     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.8349     Document Type: Review

References (23)

1. Singhal S, Birch JM, Kerr B, et al: Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child 87:65-70, 2002
2. Listernick R, Darling C, Greenwald M, et al: Optic pathway tumors in children: The effect of neurofibromatosis type 1 on clinical manifestations and natural history. J Pediatr 127:718-722, 1995
3. Guillamo JS, Creange A, Kalifa C, et al: Prognostic factors of CNS tumours in neurofibromatosis 1 (NF1): A retrospective study of 104 patients. Brain 126:152-160, 2003
4. Evans DG, Baser ME, McGaughran J, et al: Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39:311-314, 2002
5. Burger PC: Pilocytic astrocytoma, in, Kleihues P, Cavanee WK (eds): World Health Organization Classification of Tumors, Pathology and Genentics: Tumors of the Nervous System. Lyon, France, IARC Press, 2000, pp 45-51
6. National Institutes of Health Consensus Development Conference Statement: Neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987. Neurofibromatosis 1:172-178, 1988
7. Dodge HW Jr, Love JG, Craig WM, et al: Gliomas of the optic nerves. AMA Arch Neurol Psychiatry 79:607-621, 1958
8. Ron E, Modan B, Boice JD Jr, et al: Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319:1033-1039, 1988
9. Brada M, Ford D, Ashley S, et al: Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ 304:1343-1346, 1992
10. Sadetzki S, Flint-Richter P, Ben-Tal T, et al: Radiation-induced meningioma: A descriptive study of 253 cases. J Neurosurg 97:1078-1082, 2002
11. Chao RC, Pyzel U, Fridlyand J, et al: Therapy-induced malignant neoplasms in Nf1 mutant mice. Cancer Cell 8:337-348, 2005
12. Knauf JA, Ouyang B, Knudsen ES, et al: Oncogenic RAS induces accelerated transition through G2/M and promotes defects in the G2 DNA damage and mitotic spindle checkpoints. J Biol Chem 281:3800-3809, 2006
13. Ars E, Kruyer H, Morell M, et al: Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. J Med Genet 40:e82, 2003
14. Salvati M, Frati A, Russo N, et al: Radiation-induced gliomas: Report of 10 cases and review of the literature. Surg Neurol 60:60-67, 2003
15. Ron E: Cancer risks from medical radiation. Health Phys 85:47-59, 2003
16. Schneider AB, Favus MJ, Stachura ME, et al: Salivary gland neoplasms as a late consequence of head and neck irradiation. Ann Intern Med 87:160-164, 1977
17. Friedman JM, Birch PH: Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 70:138-143, 1997
18. de Vathaire F, Hawkins M, Campbell S, et al: Second malignant neoplasms after a first cancer in childhood: Temporal pattern of risk according to type of treatment. Br J Cancer 79:1884-1893, 1999
19. Korones DN, Padowski J, Factor BA, et al: Do children with optic pathway tumors have an increased frequency of other central nervous system tumors? Neuro-oncol 5:116-120, 2003
20. Evans G, Birch JM, Ramsden R, et al: Malignant transformation and new primary tumours after therapeutic radiation for benign disease: Substantial risks in certain tumour-prone syndromes. J Med Genet 43:289-294, 2005
21. Cahan WG, Woodard HQ, Higinbotham NL, et al: Sarcoma arising in irradiated bone: Report of eleven cases - 1948. Cancer 82:8-34, 1998
22. Grabenbauer GG, Schuchardt U, Buchfelder M, et al: Radiation therapy of optico-hypothalamic gliomas (OHG)-radiographic response, vision and late toxicity. Radiother Oncol 54:239-245, 2000
23. Adams C, Fletcher WA, Myles ST: Chiasmal glioma in neurofibromatosis type 1 with severe visual loss regained with radiation. Pediatr Neurol 17:80-82, 1997